News Detail
Oslo, Norway; 12 Sept 2022: Researchers headed by a team at the University of Oslo have identified a drug that is currently used to treat diarrhea, as a potential therapeutic candidate for core symptoms of autism spectrum disorder (ASD). The investigators constructed a computer m......
View Details
Source : Genetic Engineering and Biotechnology News
Loperamide
University of Oslo
diarrhea
autism spectrum disorder (ASD)
biological process underlying ASD
social interaction and communication difficulties that are associated with ASD
Frontiers in Psychiatry
Drug repurposing candidates to treat core symptoms in autism spectrum disorder
Related News
- Polyoxometalates show promise as drug transporters into the cell (06-12-2023)
- New method identifies bacteria more easily (03-12-2023)
- Spanish scientists discover a promising therapeutic target for cardiac arrhythmias (03-12-2023)
- Researchers develop one-dollar cancer treatment using engineered bacteria (01-12-2023)
- Protected droplets as a new transport route for medicines (01-12-2023)
- An Oral Probiotic Can Treat Dry Eye Disease: Study (30-11-2023)
- Researchers develop faster, cheaper, and more precise method for identifying bacteria (30-11-2023)
- Over 900 known and novel genes responsible for AMR revealed in a study (29-11-2023)
- New device could replace animals used in drug safety testing (29-11-2023)
- Decades of mRNA Research Come to Fruition (28-11-2023)